A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2013
At a glance
- Drugs ACHN 975 (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions
- 10 Jun 2013 Status changed from planning to recruiting, as reported by ClinicalTrials.gov.
- 10 Jun 2013 New source identified and integrated: ClinicalTrials.gov record.
- 01 Jun 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.